Yoga in Patients With Fibrosing Interstitial Lung Diseases
Effectiveness of Yoga in Patients With Fibrosing Interstitial Lung Diseases - a Feasibilty and Pilot Study
1 other identifier
interventional
17
1 country
1
Brief Summary
Fibrosing interstitial lung diseases are characterized by loss of lung function, which leads to a decrease in quality of life and physical capacity. Several studies have shown an increase in quality of life and physical capacity after increasing physical activity in patients. There is evicence that yoga has a positive influence in patients with chronic obstructive pulmonary diseases, but so far, studies examining the effect of yoga in patients with fibrosing interstitial lung diseases are missing. Study aims are to determine the feasibilty of this study, and to determine the effects of yoga to patients' quality of life and physical capacity. Twenty patients with a fibrosing interstitial lung disease will be recruited and randomly assigned to the intervention or control group. Several questionnaires regarding quality of life will be conducted. Furthermore, the 6 minutes walking test, a lung function test and a biomarker analysis will be conducted at baseline and follow-up. The intervention group will participate in a 12 week yoga class, whereas the controll group will not participate. Yoga classes will be offered to the control group after the study. In addition, focus group interviews will be conducted at baseline and follow-up with the intervention group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2018
CompletedFirst Submitted
Initial submission to the registry
May 14, 2019
CompletedFirst Posted
Study publicly available on registry
June 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2020
CompletedDecember 7, 2020
December 1, 2020
1.1 years
May 14, 2019
December 4, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Change from baseline quality of life at 12 weeks: King's Brief Interstitial Lung Disease Questionnaire (K-BILD)
Quality of life will be measured with King's Brief Interstitial Lung Disease Questionnaire (K-BILD). It is a 15-item validated questionnaire assessing health status in patients with an interstitial lung disease. Questions are related to three domains: breathlessness and activities, psychological aspects, and chest symptoms. Each question has 7 possible answers. The questionnaire has a scale from 0 - 100, in which 100 means highest quality of life.
baseline and 12 week follow-up
Change in physical capacity
Physical capacity will be measured by the 6 miuntes walking test
baseline and 12 week follow-up
Feasibility of a yoga class in patients with fibrosing interstitial lung diseases: focus group interview
Evaluation of the study by a focus group interview
12 week follow-up
Change from baseline quality of life at 12 weeks: Hospital Anxiety and Depression Scale (HADS)
Quality of life will be measured with the Hospital Anxiety and Depression Scale (HADS). It is a 14-item questionnaire, 7 items are related to depression and 7 items are related to anxiety. Each question has 4 different answer options, each scored from 0-3. Scores are summed up for each field (depression or anxiety) with 0 points as lowest possibility and 21 scores as highest (0-7 = normal, 8-10 = borderline abnormal, and 11-21 = abnormal).
baseline and 12 week follow-up
Change from baseline quality of life at 12 weeks: Interstitial Lung Disease Anxiety-questionnaire
Quality of life will be measured with Interstitial Lung Disease Anxiety-questionnaire. This is a 37-item questionnaire with 5 answer possibilities for each question (never, rare, sometimes, often, always). Total scores are a sum of all questions. Lowest score = 0, highest score = 136. The higher the score the better is the patients' quality of life.
baseline and 12 week follow-up
Expectations of study by participants
Evaluation of the study by a focus group interview
baseline
Study Arms (2)
Intervention group
EXPERIMENTALIntervention will be a 12 week yoga class
Control group
NO INTERVENTIONControl group will not participate in the 12 week yoga class but will participate in Surveys, 6 minute walking test, lung function test, and biomarker analysis. Furthermore, they will be offered a yoga class after the study.
Interventions
Intervention is a 12 week yoga class with classes twice a week. Each yoga class will last about 1 hour. Furthermore, focus group interviews will be conducted after the first and last yoga class.
Eligibility Criteria
You may qualify if:
- ability to understand study and study procedure
- diagnosis of fibrosing interstitial lung disease
- Age: \> 18 years
- Ability to consent
You may not qualify if:
- Forced Vital Capacity \< 50%
- Oxygen therapy
- diagnosis of pulmonary hypertension
- participant does not understand the study
- pulmonary infection within the last 4 weeks
- acute exacerbation within the last 4 weeks
- other respiratory decline within the last 4 weeks
- co-morbidities which make yoga training impossible
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Heidelberg Universitylead
- Lungenfibrose e.V.collaborator
Study Sites (1)
Thoraxklinik-Heidelberg
Heidelberg, 69126, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Kreuter, Prof.
Heidelberg University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Clinical Professor
Study Record Dates
First Submitted
May 14, 2019
First Posted
June 7, 2019
Study Start
December 1, 2018
Primary Completion
December 31, 2019
Study Completion
May 31, 2020
Last Updated
December 7, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share